1-2 of 2
Jingxin Fu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network

Zexian Zeng, Jingxin Fu, Carrie Cibulskis, Aashna Jhaveri, Curtis Gumbs, Biswajit Das, Beatriz Sanchez-Espiridion, Sylvie Janssens, Len Taing, Jin Wang, James Lindsay, Tomas Vilimas, Jianhua Zhang, Collin Tokheim, Avinash Sahu, Peng Jiang, Chunhua Yan, Dzifa Yawa Duose, Ethan Cerami, Li Chen, David Cohen, Qingrong Chen, Rebecca Enos, Xin Huang, Jack J. Lee, Yang Liu, Donna S. Neuberg, Cu Nguyen, Candace Patterson, Sharmistha Sarkar, Sachet Shukla, Ming Tang, Junko Tsuji, Mohamed Uduman, Xiaoman Wang, Jason L. Weirather, Jijun Yu, Joyce Yu, Jianjun Zhang, Jiexin Zhang, Daoud Meerzaman, Magdalena Thurin, Andrew Futreal, Chris Karlovich, Stacey B. Gabriel, Ignacio Ivan Wistuba, X. Shirley Liu, Catherine J. Wu
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (18): 5049–5061.
https://doi.org/10.1158/1078-0432.CCR-20-3251
Published: 15 September 2021
View article titled, Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network
Open the PDF for Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network in another window
Includes: Supplementary data
Journal Articles

Inhibition of MAN2A1 Enhances the Immune Response to Anti–PD-L1 in Human Tumors

Sailing Shi, Shengqing Gu, Tong Han, Wubing Zhang, Lei Huang, Ziyi Li, Deng Pan, Jingxin Fu, Jun Ge, Myles Brown, Peng Zhang, Peng Jiang, Kai W. Wucherpfennig, X. Shirley Liu
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (22): 5990–6002.
https://doi.org/10.1158/1078-0432.CCR-20-0778
Published: 13 November 2020
View article titled, Inhibition of MAN2A1 Enhances the Immune Response to Anti–PD-L1 in Human Tumors
Open the PDF for Inhibition of MAN2A1 Enhances the Immune Response to Anti–PD-L1 in Human Tumors in another window
Includes: Supplementary data